Equity Overview
Price & Market Data
Price: $0.616
Daily Change: +$0.0117 / 1.90%
Daily Range: $0.60 - $0.705
Market Cap: $3,602,485
Daily Volume: 26,805
Performance Metrics
1 Week: -16.79%
1 Month: -23.27%
3 Months: -37.17%
6 Months: -30.83%
1 Year: -67.93%
YTD: -37.80%
Details
Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. The company was incorporated in 2004 and is based in Isfiya, Israel.